Table 1.

Comparison of EA patients and controls

	Patients with EA	Controls	P-value
Age [years]	31.6 ± 16,9	31.4 ± 16.5	0.972
male/female	19/12	17/14	0.610
ECG
QRS-duration [ms]	123.35 ± 26.36	97.33 ± 11.89	< 0.001
QTc-duration [ms]	424.26 ± 37.19	400.67 ± 23.66	0.004
Heart failure
NYHA	2.62 ± 0.62	n/A
BNP [ng/l]	78.32 ± 128.85	n/A
Disease severity
R/L Index	2.58 ± 1.66
Dyssynchrony,
C-SDI [%]	7.70 ± 3.38	3.80 ± 0.91	< 0.001
CURE	0.77 ± 0.05	0.86 ± 0.03	< 0.001
4D–SDI [%]	7.60 ± 4.58	2.54 ± 0.62	< 0.001
LV Volumetric Paramters
EDVi [ml/m2]	72.41 ± 11.13	82.67 ± 15.14	0.012
ESVi [ml/m2]	29.78 ± 8.66	27.55 ± 8.02	0.135
EF [%]	58.82 ± 7.94	67.03 ± 5.41	< 0.001

Significant differences (p < 0.05) are printed italic